Reviva Pharmaceuticals Holdings, Inc.
RVPH
$0.35
-$0.44-55.73%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.82M | 1.90M | 2.35M | 2.42M | 1.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.56M | 4.03M | 6.07M | 6.54M | 6.28M |
| Operating Income | -3.56M | -4.03M | -6.07M | -6.54M | -6.28M |
| Income Before Tax | -3.36M | -4.01M | -6.05M | -6.43M | -6.25M |
| Income Tax Expenses | 2.90K | 2.80K | 8.00K | 5.20K | 4.70K |
| Earnings from Continuing Operations | -3.37M | -4.01M | -6.05M | -6.43M | -6.26M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.37M | -4.01M | -6.05M | -6.43M | -6.26M |
| EBIT | -3.56M | -4.03M | -6.07M | -6.54M | -6.28M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.57 | -1.10 | -2.43 | -2.64 | -3.07 |
| Normalized Basic EPS | -0.35 | -0.69 | -1.52 | -1.65 | -1.92 |
| EPS Diluted | -0.57 | -1.10 | -2.43 | -2.64 | -3.07 |
| Normalized Diluted EPS | -0.35 | -0.69 | -1.52 | -1.65 | -1.92 |
| Average Basic Shares Outstanding | 5.94M | 3.63M | 2.49M | 2.43M | 2.04M |
| Average Diluted Shares Outstanding | 5.94M | 3.63M | 2.49M | 2.43M | 2.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |